Complete GIST Resection Increased With Prolonged Preoperative Imatinib

The use of imatinib mesylate preoperatively for a maximum of 12 months resulted in a high rate of complete microscopic resection in a group of patients with marginally resectable gastrointestinal stromal tumor (GIST), according to the results of a phase II trial.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news